|
End-of-day quote
Other stock markets
|
||
| - USD | - |
|
| 06-29 | Social Buzz: Wallstreetbets Stocks Advance Premarket Monday; SELLAS Life Sciences, Strategy to Open Higher | MT |
| 05-12 | SELLAS Life Sciences Group Q1 Loss Narrows | MT |
| Market Cap | 2.02B 1.76B 1.64B 1.5B 2.84B 193B 2.88B 19.3B 7.57B 96.16B 7.6B 7.43B 322B | P/E 2026 * |
-49x | P/E 2027 * | -82.3x |
|---|---|---|---|---|---|
| Enterprise Value | 2.02B 1.76B 1.64B 1.5B 2.84B 193B 2.88B 19.3B 7.57B 96.16B 7.6B 7.43B 322B | EV / Sales 2026 * |
-
| EV / Sales 2027 * | 38.1x |
| Free-Float |
99.05% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: GALA BIOP
| Manager | Title | Age | Since |
|---|---|---|---|
Angelos Stergiou
CEO | Chief Executive Officer | 50 | 2017-12-28 |
John Burns
DFI | Director of Finance/CFO | 41 | 2017-12-29 |
Stacy Yeung
CMP | Compliance Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Angelos Stergiou
BRD | Director/Board Member | 50 | 2017-12-28 |
John Varian
CHM | Chairman | 66 | 2024-05-31 |
| Director/Board Member | 69 | 2017-12-28 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +2.35% | +0.77% | +29.92% | +85.38% | 55.23B | |
| -0.21% | -7.38% | +25.34% | +63.02% | 53.75B | |
| -1.94% | +1.68% | -15.51% | -16.57% | 23.48B | |
| -3.79% | -8.60% | -8.90% | +342.42% | 22B | |
| +2.49% | -1.27% | +15.99% | -10.53% | 19.78B | |
| +0.79% | -1.06% | +29.29% | -33.32% | 17.44B | |
| +0.58% | -7.23% | +24.50% | +519.07% | 14.66B | |
| -4.60% | -3.97% | +46.80% | +169.76% | 14.07B | |
| +3.41% | -7.83% | +161.76% | +284.91% | 13.02B | |
| Average | -0.09% | -1.43% | +34.35% | +156.02% | 25.94B | |
| Weighted average by Cap. | +0.18% | +0.09% | +27.44% | +120.65% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | - | 53.09M 46.15M 42.96M 39.44M 74.48M 5.07B 75.64M 506M 199M 2.52B 199M 195M 8.46B |
| Net income | -37.97M -33.01M -30.73M -28.21M -53.27M -3.63B -54.1M -362M -142M -1.8B -143M -139M -6.05B | -26.29M -22.85M -21.27M -19.53M -36.88M -2.51B -37.45M -251M -98.4M -1.25B -98.72M -96.55M -4.19B |
| Net Debt | - | - |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Select your edition
All financial news and data tailored to specific country editions
